Close Menu

Massachusetts General Hospital's Jack Szostak tells The New York Times that his work on telomeres, which led him to win the 2009 Nobel Prize, started out as a "side project." Szostak was interested in recombination, and he became interested in telomeres because they do not recombine. And he then worked with Elizabeth Blackburn, who shared the Nobel with him.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.